From December 27, 2023 to March 31, 2024, the company has repurchased 3,505,808 shares, representing 0.18% for CNY 15.59 million. With this, the company has completed the repurchase of 3,505,808 shares, representing 0.18% for CNY 15.59 million under the buyback announced on December 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 CNY | +0.52% | -5.11% | -16.31% |
May. 28 | Huapont Life Sciences Co.,Ltd Implements Final Cash Dividend for 2023, Payable on June 03, 2024 | CI |
May. 24 | Huapont Life Sciences Co.,Ltd Approves Cash Dividend for 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-16.31% | 1.06B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- 002004 Stock
- News Huapont Life Sciences Co.,Ltd
- Tranche Update on Huapont Life Sciences Co.,Ltd's Equity Buyback Plan announced on December 28, 2023.